Hiransuthikul, A., Thammajaruk, N., Kerr, S., Janamnuaysook, R., Nonenoy, S., Hongchookiat, P., . . . team, t. i. s. No significant drug−drug interaction between oral TAF‐based PrEP and feminizing hormone therapy among transgender women in Thailand: The iFACT‐3 study. Wiley.
Chicago Style (17th ed.) CitationHiransuthikul, Akarin, et al. No Significant Drug−drug Interaction Between Oral TAF‐based PrEP and Feminizing Hormone Therapy Among Transgender Women in Thailand: The IFACT‐3 Study. Wiley.
MLA (9th ed.) CitationHiransuthikul, Akarin, et al. No Significant Drug−drug Interaction Between Oral TAF‐based PrEP and Feminizing Hormone Therapy Among Transgender Women in Thailand: The IFACT‐3 Study. Wiley.
Warning: These citations may not always be 100% accurate.